Bafna Pharmaceuticals Limited (BAFNAPH.NS) - Quarterly Income Statement

Home
BAFNAPH.NS
Financials

79.14 (INR) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1
Revenue Numbers are in millions	332.863	413.981	284.422	406.782	419.471	422.438	342.184	219.608	169.268	149.825	204.601	284.392	212.586	218.405	174.753	151.996	167.025	131.329	109.252	115.651	68.493	225.698	130.749	88.379	104.232	592.963	259.909	521.185	341.154
Cost of Revenue Numbers are in millions	316.768	348.859	232.917	287.935	265.83	278.422	245.134	137.879	104.506	96.481	123.791	161.792	130.794	126.439	111.845	99.236	117.036	46.846	71.318	88.646	63.427	178.802	89.107	56.517	83.465	457.439	156.812	475.6	235.86
Gross Profit Numbers are in millions	16.095	65.122	51.505	118.847	153.641	144.016	97.05	81.729	64.762	53.344	80.81	122.6	81.792	91.966	62.908	52.76	49.989	84.483	37.934	27.005	5.066	46.896	41.642	31.862	20.767	135.524	103.097	45.585	105.294
Gross Profit Ratio Numbers are in millions	0.048	0.157	0.181	0.292	0.366	0.341	0.284	0.372	0.383	0.356	0.395	0.431	0.385	0.421	0.36	0.347	0.299	0.643	0.347	0.234	0.074	0.208	0.318	0.361	0.199	0.229	0.397	0.087	0.309
Reseach & Development Expenses Numbers are in millions	0	0	0	0	0	15.212	0	0	0	14.728	0	0	0	13.589	0	0	0	10.095	0	0	0	7.527	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	18.425	0	0	0	40.469	0	0	0	10.161	0	0	0	33.318	0	0	0	50.99	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	3.664	0	0	0	0.963	0	0	0	0.563	0	0	0	0.619	0	0	0	0.562	0	0	0	0	0	0	0
SG&A Numbers are in millions	18.424	48.959	26.964	30.32	42.735	22.089	22.369	18.958	35.019	41.432	36.346	38.988	14.354	10.724	32.537	30.151	17.936	33.937	24.194	24.348	23.149	51.552	22.199	21.792	20.612	0	0	0	0
Other Expenses Numbers are in millions	-3.45	5.153	9.791	1.59	18.691	-0.836	14.127	6.422	13.014	4.272	4.873	1.764	1.7	-4.344	0.391	2.271	1.755	-9.184	0.329	5.913	3.017	3.508	3.101	-0.347	0	134.392	57.771	-20.852	57.698
Operating Expenses Numbers are in millions	21.874	48.959	84.963	91.219	102.815	79.637	75.521	67.558	61.03	68.234	64.544	79.857	61.562	61.74	51.005	50.033	33.465	46.466	45.739	37.982	43.911	84.294	38.942	37.554	37.421	134.392	57.771	-20.852	57.698
Operating Income Numbers are in millions	-5.779	16.163	-23.667	29.218	50.826	63.543	35.656	20.593	3.732	-12.829	16.265	42.743	20.23	30.226	11.903	4.999	16.524	38.017	-7.805	-10.977	-38.845	-37.398	2.7	-5.692	-16.654	1.132	45.326	66.437	47.596
Operating Income Ratio Numbers are in millions	-0.017	0.039	-0.083	0.072	0.121	0.15	0.104	0.094	0.022	-0.086	0.079	0.15	0.095	0.138	0.068	0.033	0.099	0.289	-0.071	-0.095	-0.567	-0.166	0.021	-0.064	-0.16	0.002	0.174	0.127	0.14
Total Other Income Expenses Net Numbers are in millions	-1.457	-1.609	-5.757	-4.379	12.685	-7.041	-5.707	-4.504	9.889	3.331	0.763	-18.98	0.64	-3.866	-2.899	-0.212	1.592	202.088	-215.838	5.468	1.749	-97.748	-1.533	-6.54	-7.257	-10.401	-27.778	-25.524	-26.298
Income Before Tax Numbers are in millions	-7.236	14.554	-29.424	24.839	63.511	56.502	29.949	16.089	13.621	11.415	17.028	23.763	20.87	26.36	9.004	4.787	18.116	240.105	-223.643	-5.509	-37.096	-135.146	1.167	-12.232	-23.911	-9.269	17.548	40.913	21.298
Income Before Tax Ratio Numbers are in millions	-0.022	0.035	-0.103	0.061	0.151	0.134	0.088	0.073	0.08	0.076	0.083	0.084	0.098	0.121	0.052	0.031	0.108	1.828	-2.047	-0.048	-0.542	-0.599	0.009	-0.138	-0.229	-0.016	0.068	0.078	0.062
Income Tax Expense Numbers are in millions	0	12.667	12.748	12.289	18.691	2.783	-0.003	11.158	13.014	23.876	4.873	1.764	1.701	-6.646	0.39	0	1.756	15.778	-0.352	5.913	-15.822	10.56	0.533	-0.348	0.057	-4.02	3.463	4.66	10.686
Net Income Numbers are in millions	-7.236	14.554	-29.424	24.839	63.511	53.719	29.952	16.089	13.621	-10.15	17.028	23.763	20.87	26.36	9.004	4.787	18.116	-4.133	-223.291	-5.509	-21.275	-140.808	0.634	-12.232	-23.968	-5.754	14.085	36.253	10.612
Net Income Ratio Numbers are in millions	-0.022	0.035	-0.103	0.061	0.151	0.127	0.088	0.073	0.08	-0.068	0.083	0.084	0.098	0.121	0.052	0.031	0.108	-0.031	-2.044	-0.048	-0.311	-0.624	0.005	-0.138	-0.23	-0.01	0.054	0.07	0.031
EPS Numbers are in millions	-0.31	0.62	-1.24	1.05	2.68	2.27	1.27	0.68	0.58	-0.45	0.72	0.95	0.88	1.11	0.38	0.2	7.66	-1.75	-9.44	-0.25	-0.9	-59.54	0.04	-0.52	-10.1	-2.43	0.75	1.11	0.58
EPS Diluted Numbers are in millions	-0.31	0.62	-1.24	1.05	2.68	2.27	1.27	0.68	0.58	-0.45	0.72	0.95	0.88	1.11	0.38	0.2	7.66	-1.75	-9.44	-0.25	-0.9	-59.54	0.04	-0.52	-10.1	-2.43	0.75	1.11	0.58
EBITDA Numbers are in millions	8.66	28.874	-10.959	41.629	81.642	78.795	49.64	31.837	29.61	24.408	33.221	58.735	36.54	38.567	22.478	15.135	27.754	35.064	219.385	2.163	-25.65	-17.08	14.824	1.484	-7.051	29.741	65.57	82.424	65.253
EBITDA Ratio Numbers are in millions	0.026	0.07	-0.039	0.102	0.195	0.187	0.145	0.145	0.175	0.163	0.162	0.207	0.172	0.177	0.129	0.1	0.166	0.267	2.008	0.019	-0.374	-0.076	0.113	0.017	-0.068	0.05	0.252	0.158	0.191

Bafna Pharmaceuticals Limited

NSE:BAFNAPH.NS Add to watchlist

NSE:BAFNAPH.NS